Lonza Group AG (SWX: LONN)

Market Cap	38.35B
Revenue (ttm)	6.70B
Net Income (ttm)	573.00M
Shares Out	72.23M
EPS (ttm)	7.92
PE Ratio	67.02
Forward PE	35.09
Dividend	4.00 (0.75%)
Ex-Dividend Date	n/a

Volume	400,419
Open	521.60
Previous Close	528.20
Day's Range	516.80 - 531.60
52-Week Range	339.00 - 589.40
Beta	0.65
Analysts	n/a
Price Target	n/a
Earnings Date	Jan 29, 2025

About Lonza Group AG

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substanc...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1897
• Employees: 18,000
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: LONN

Financial Performance

In 2023, Lonza Group AG's revenue was 6.72 billion, an increase of 7.94% compared to the previous year's 6.22 billion. Earnings were 654.00 million, a decrease of -46.17%.